Topic: Renal and Hepatic Impairment

Worked Hepatic Impairment Model for a Metabolized Drug

Worked Renal Impairment Model for Mixed-Clearance Drugs

Translating Renal and Hepatic Disease Phenotypes into PBPK Changes

Turning Impairment Predictions into Dose Recommendations

Uremia-Driven Changes in Plasma Protein Binding

Using Child-Pugh and MELD Scores in PBPK Models

Using Parent-Metabolite Profiles to Diagnose Liver Disease Effects

Separating Intrinsic Clearance Changes from Hepatic Delivery

Separating Glomerular Filtration Loss from Tubular Dysfunction

Representing Residual Renal Function Across CKD Stages